High-molecular-weight serum protein complexes differentially promote cell migration and the focal adhesion localization of the urokinase receptor in human glioma cells

Experimental Cell Research

Volumn 257, Issue 1, 2000, Pages 67-81

  Hedberg, Karen K ^a   Stauff, Corinne ^a   Høyer Hansen, Gunilla ^b   Rønne, Ebbe ^b   Griffith, O Hayes ^a  

^a UNIVERSITY OF OREGON   (United States)

^b FINSEN LABORATORY   (Denmark)

Author keywords

Immunogold; Laminin; Migration; Photoelectron microscopy; uPAR; Vitronectin

Indexed keywords

LAMININ; PLASMA PROTEIN; UROKINASE RECEPTOR; VITRONECTIN;

ARTICLE; CELL MIGRATION; ELECTRON MICROSCOPY; FETUS; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL;

EID: 0034713419     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4873     Document Type: Article

References (41)

1. Abe T., Mori T., Kohno K., Seiki M., Hayakawa T., Welgus H. G., Hori S., Kuwano M. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Clin. Exp. Metastasis. 12:1994;296-304.
2. Bastholm L., Nielsen M. H., DeMey J., Danø K., Brunner N., Høyer-Hansen G., Rønne E., Elling F. Confocal fluorescence microscopy of urokinase plasminogen activator receptor and cathepsin D in human MDA-MB-231 breast cancer cells migrating in reconstituted basement membrane. Biotech. Histochem. 69:1994;61-67.
3. Behrendt N., Ploug M., Patthy L., Houen G., Blasi F., Danø K. The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J. Biol. Chem. 266:1991;7842-7847.
4. Behrendt N., Ploug M., Rønne E., Høyer-Hansen G., Danø K. Cellular receptor for urokinase-type plasminogen activator: Protein structure. Methods in Enzymology. 1993;Academic Press, New York. p. 207-222.
5. Behrendt N., Stephens R. W. The urokinase receptor. Fibrinolysis Proteolysis. 12:1998;191-194.
6. Busso N., Masur S. K., Lazega D., Waxman S., Ossowski L. Induction of cell migration by pro-urokinase binding to its receptor: Possible mechanism for signal transduction in human epithelial cells. J. Cell Biol. 126:1994;259-270.
7. Chintala S. K., Mohanam S., Go Y., Venkaiah B., Sawaya R., Gokaslan Z. L., Rao J. S. Altered in vitro spreading and cytoskeletal organization in human glioma cells by downregulation of urokinase receptor. Mol. Carcinog. 20:1997;355-365.
8. Del Rosso M., Pedersen N., Fibbi G., Pucci M., Dinni G., Anichini E., Blasi F. Selective localization of receptors for urokinase aminoterminal fragment at substratum contact sites of an in vitro established line of human epidermal cells. Exp. Cell Res. 203:1992;427-434.
9. Ellis V., Scully M. F., Kakkar V. V. Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J. Biol. Chem. 264:1989;2185-2188.
10. Friedlander D. R., Zagzag D., Shiff B., Cohen H., Allen J. C., Kelly P. J., Grumet M. Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves alphaV and beta1 integrins. Cancer Res. 56:1996;1939-1947.
11. Griffith O. H., Hedberg K. K. Photoelectric effect and photoelectron microscopy. Encyclopedia of Human Biology. 1997;Academic Press, New York. p. 801-806.
12. Haugland H. K., Tysnes B. B., Tysnes O. B. Adhesion and migration of human glioma cells are differently dependent on extracellular matrix molecules. Anticancer Res. 17:1997;1035-1042.
13. Hedberg K. K., Birrell G. B., Habliston D. L., Griffith O. H. Tunable label contrast on the cell surface: Photoelectron imaging with multiple wavelength excitation. J. Microsc. Soc. Am. 1:1995;253-261.
14. Høyer-Hansen G., Ploug M., Behrendt N., Rønne E., Danø K. Cell-surface acceleration of urokinase-catalyzed receptor cleavage. Eur. J. Biochem. 243:1997;21-26.
15. Høyer-Hansen G., Rønne E., Solberg H., Behrendt N., Ploug M., Lund L. R., Ellis V., Danø K. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J. Biol. Chem. 267:1992;18224-18229.
16. Høyer-Hansen G., Behrendt N., Ploug M., Danø K., Preissner K. T. The intact urokinase receptor is required for efficient vitronectin binding: Receptor cleavage prevents ligand interaction. FEBS Lett. 420:1997;79-85.
17. Laterra J., Rosen N., Ranganathan S., Fielding K., Johnston P. Scatter factor/hepatocyte growth factor expression enhances human glioblastoma tumorigenicity and growth. Biochem. Biophys. Res. Commun. 235:1997;743-747.
18. Mahesparan R., Tysnes B. B., Edvardsen K., Haugeland H. K., Garcia Cabrera I., Lund-Johansen M., Engebraaten O., Bjerkvig R. Role of high molecular weight extracellular matrix proteins in glioma cell migration. Neuropathol. Appl. Neurobiol. 23:1997;102-112.
19. Mohanam S., Sawaya R., McCutcheon I., Ali-Osman F., Boyd D., Rao J. S. Modulation of in vitro invasion of human glioblastoma cells by urokinase-type plasminogen activator receptor antibody. Cancer Res. 53:1993;4143-4147.
20. Myöhänen H. T., Stephens R. W., Hedman K., Tapiovaara H., Rønne E., Høyer-Hansen G., Danø K., Vaheri A. Distribution and lateral mobility of the urokinase receptor complex at the cell surface. J. Histochem. Cytochem. 41:1993;1291-1301.
21. Planus E., Barlovatz-Meimon G., Rogers R. A., Bonavaud S., Ingber D. E., Wang N. Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading. J. Cell Sci. 110:1997;1091-1098.
22. Ploug M., Rønne E., Behrendt N., Jensen A. L., Blasi F., Danø K. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosylphosphatidylinositol. J. Biol. Chem. 266:1991;1926-1933.
23. Quax P. H., Grimbergen J. M., Lansink M., Bakker A. H., Blatter M. C., Belin D., van Hinsbergh V. W., Verheijen J. H. Binding of human urokinase-type plasminogen activator to its receptor: Residues involved in species specificity and binding. Arterioscler. Thromb. Vasc. Biol. 18:1998;693-701.
24. Rempel S. A., Rosenblum M. L., Mikkelsen T., Yan P.-S., Ellis K. D., Golembieski W. A., Sameni M., Rozhin J., Ziegler G., Sloane B. Cathepsin B expression and localization in glioma progression and invasion. Cancer Res. 54:1994;6027-6031.
25. Rempfer G. F., Skoczylas W. P., Griffith O. H. Design and performance of a high-resolution photoelectron microscope. Ultramicroscopy. 36:1991;196-221.
26. Rønne E., Behrendt N., Ellis V., Ploug M., Danø K., Høyer-Hansen G. Cell-induced potentiation of the plasminogen activation system is abolished by a monoclonal antibody that recognizes the NH2-terminal domain of the urokinase receptor. FEBS Lett. 288:1991;233-236.
27. Rønne E., Behrendt N., Ploug M., Nielsen H. J., Wollisch E., Weidle U., Danø K., Høyer-Hansen G. Quantitation of the receptor for urokinase plasminogen activator by enzyme-linked immunoabsorbent assay. J. Immunol. Methods. 167:1994;91-101.
28. Sitrin R. G., Gyetko M. R., Kole K. L., McKeever P., Varani J. Expression of heterogeneous profiles of plasminogen activators and plasminogen activator inhibitors by human glioma lines. Cancer Res. 50:1990;4957-4961.
29. Solberg H., Løber D., Eriksen J., Ploug M., Rønne E., Behrendt N., Danø K., Høyer-Hansen G. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activor. Eur. J. Biochem. 205:1992;451-458.
30. Stahl A., Mueller B. M. Binding of urokinase to its receptor promotes migration and invasion of human melanoma cells in vitro. Cancer Res. 54:1994;3066-3071.
31. Stahl A., Mueller B. M. Melanoma cell migration on vitronectin: Regulation by components of the plasminogen activation system. Int. J. Cancer. 71:1997;116-122.
32. Stoppelli M. P., Corti A., Soffientini A., Cassani G., Blasi F., Assoian R. K. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc. Natl. Acad. Sci. USA. 82:1985;4939-4943.
33. Tolosa E., Shaw S. A fluorogenic assay of endogenous phosphatase for assessment of cell adhesion. J. Immunol. Methods. 192:1996;165-172.
34. Umezawa K., Asakura S., Jin Y. M., Matsuda M. Localization of vitronectin- and fibronectin-receptors on cultured human glioma cells. Brain Res. 659:1994;23-32.
35. Waltz D. A., Natkin L. R., Fujita R. M., Wei Y., Chapman H. A. Plasmin and plasminogen activator inhibitor type I promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J. Clin. Invest. 100:1997;58-67.
36. Wei Y., Waltz D. A., Rao N., Drummond R. J., Rosenberg S., Chapman H. A. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269:1994;32380-32388.
37. Wilcox S. A., Reho T., Higgins P. J., Tominna-Sebald E., McKeown-Longo P. J. Localization of urokinase to focal adhesions by human fibrosarcoma cells synthesizing recombinant vitronectin. Biochem. Cell Biol. 74:1996;899-910.
38. 3 integrins of fibrosarcoma cells: Dependence on extracellular matrix components. Cancer Res. 57:1997;1682-1689.
39. Yamamoto M., Sawaya R., Mohanam S., Rao V. H., Bruner J. M., Nicolson G. L., Rao J. S. Expression and localization of urokinase-type plasminogen activator receptor in human gliomas. Cancer Res. 54:1994;5016-5020.
40. Yebra M., Parry G. C. N., Strömblad S., Mackman N., Rosenberg S., Mueller B. M., Cheresh D. A. Requirement for receptor-bound urokinase-type plasminogen activator for integrin αvβ5-directed cell migration. J. Biol. Chem. 271:1996;29393-29399.
41. Zhang S., Laurent M., Lopez-Alemany R., Mazar A., Henkin J., Rønne E., Burtin P. Comparative localization of receptors for plasmin and for urokinase on MCF-7 cells. Exp. Cell Res. 207:1993;290-299.